Angiotensin II-induced hypertension is modulated by nuclear factor-κB in the paraventricular nucleus

Hypertension

Volumn 59, Issue 1, 2012, Pages 113-121

  Cardinale, Jeffrey P ^a   Sriramula, Srinivas ^a   Mariappan, Nithya ^a   Agarwal, Deepmala ^a   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

angiotensin II; cytokines; hypertension; superoxide; transcription factors

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; OLIGODEOXYNUCLEOTIDE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE MEASUREMENT; BRAIN TISSUE; CONTROLLED STUDY; HYPERTENSION; MALE; MICROINJECTION; NONHUMAN; OSMOTIC PUMP; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TELEMETRY; UPREGULATION;

ANGIOTENSIN II; ANIMALS; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE TYPE I; NOREPINEPHRINE; OLIGODEOXYRIBONUCLEOTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; VASOCONSTRICTOR AGENTS;

EID: 83655184676     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.182154     Document Type: Article

References (46)

1. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403. (Pubitemid 34225673)
2. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2003;285: R498-R511. (Pubitemid 37040553)
3. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006;98:121-128. (Pubitemid 43902687)
4. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central Ang II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271-H2279. (Pubitemid 40604115)
5. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, Francis J. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res. 2009; 82:503-512.
6. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91:1038-1045. (Pubitemid 35416641)
7. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 2006;25:6731-6748. (Pubitemid 44657849)
8. Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks CM, Francis J. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension. 2010;56:437-444.
9. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr. 2001;86(suppl 1):S121-S127. (Pubitemid 32916187)
10. Zhang ZH, Wei SG, Francis J, Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF-in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol. 2003;284: R916-R927.
11. Xia H, Lazartigues E. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem. 2008;107:1482-1494.
12. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res. Epub ahead of print September 27, 2011.
13. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest. 2000;106:103-106. (Pubitemid 30437245)
14. de Wardener HE. The hypothalamus and hypertension. Physiol Rev. 2001;81:1599-1658. (Pubitemid 32947779)
15. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008;51: 1345-1351.
16. Simpson JB. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology. 1981;32:248-256. (Pubitemid 11134024)
17. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol. 2000;27:422-427. (Pubitemid 30313446)
18. Shi P, Raizada MK, Sumners C. Brain cytokines as neuromodulators in cardiovascular control. Clin Exp Pharmacol Physiol. 2010;37:e52-e57.
19. Lu Y, Chen J, Yin X, Zhao H. Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 in the paraventricular nucleus. Neurol Res. 2009;31:420-424.
20. Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci. 2004;24: 9944-9952. (Pubitemid 39463575)
21. Feng Y, Yue X, Xia H, Bindom SM, Hickman PJ, Filipeanu CM, Wu G, Lazartigues E. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ Res. 2008;102:729-736. (Pubitemid 351457863)
22. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071. (Pubitemid 27163860)
23. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med. 1997;3:894-899. (Pubitemid 27353450)
24. Morishita R, Higaki J, Tomita N, Ogihara T. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res. 1998;82:1023-1028. (Pubitemid 28249063)
25. Moellering D, McAndrew J, Jo H, Darley-Usmar VM. Effects of pyrrolidine dithiocarbamate on endothelial cells: protection against oxidative stress. Free Radic Biol Med. 1999;26:1138-1145. (Pubitemid 29262699)
26. Gorbea-Oppliger VJ, Fink GD. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J Pharmacol Exp Ther. 1995;273:611-616.
27. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol. 2003;139:191-202. (Pubitemid 36760351)
28. Silva AQ, Santos RA, Fontes MA. Blockade of endogenous angiotensin-( 1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension. 2005;46:341-348. (Pubitemid 41099167)
29. Xu P, Sriramula S, Lazartigues E. Ace2/ang-(1-7)/mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol. 2011;300:R804-R817.
30. Diez-Freire C, Vazquez J, Correa de Adjounian MF, Ferrari MF, Yuan L, Silver X, Torres R, Raizada MK. Ace2 gene transfer attenuates hypertension-linked pathophysiological changes in the shr. Physiol Genomics. 2006;27:12-19. (Pubitemid 44511821)
31. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension. 2006;47: 515-521. (Pubitemid 43843868)
32. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension. 2007;49:926-931. (Pubitemid 351664196)
33. Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension. 2009;53:210-216.
34. Cowling RT, Gurantz D, Peng J, Dillmann WH, Greenberg BH. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mrna in rat cardiac fibroblasts treated with tumor necrosis factor-αor interleukin-1β. J Biol Chem. 2002;277:5719-5724. (Pubitemid 34968348)
35. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004;95:210-216. (Pubitemid 38988688)
36. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension. 2002;39:275-280. (Pubitemid 34165228)
37. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 2005;46:533-539. (Pubitemid 41376834)
38. Guggilam A, Cardinale JP, Mariappan N, Sriramula S, Haque M, Francis J. Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide. Basic Res Cardiol. 2011;106:273-286.
39. Liu JL, Murakami H, Zucker IH. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res. 1998;82:496-502. (Pubitemid 28117331)
40. Wang Y, Liu XF, Cornish KG, Zucker IH, Patel KP. Effects of nnos antisense in the paraventricular nucleus on blood pressure and heart rate in rats with heart failure. Am J Physiol Heart Circ Physiol. 2005;288: H205-H213. (Pubitemid 40023848)
41. Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR, Francis J. Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between NNOS, AT-1r and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail. 2008;10:625-634.
42. Li YF, Wang W, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1035-R1043.
43. Campese VM, Ye S, Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1βmediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 2002;39:519-524. (Pubitemid 34165176)
44. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci. 2002;98:24-27. (Pubitemid 34627010)
45. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via akt-dependent pathways. Hypertension. 2007;49:185-192. (Pubitemid 46360359)
46. Sinnayah P, Lindley TE, Staber PD, Cassell MD, Davidson BL, Davisson RL. Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension. 2002;39:603-608. (Pubitemid 34165191)